A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and secondary equity financing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback